Wendel-Garcia, Pedro David http://orcid.org/0000-0001-7775-3279
Eberle, Barbara
Kleinert, Eva-Maria
Hilty, Matthias Peter
Blumenthal, Stephan
Spanaus, Katharina
Fodor, Patricia
Maggiorini, Marco
Funding for this research was provided by:
Baxter International Foundation
Article History
Received: 29 September 2023
Accepted: 6 December 2023
First Online: 14 December 2023
Declarations
:
: The trial was approved by the Swiss regional cantonal ethical commission (EK-ZH 2012-0458, ClinicalTrials.gov NCT01948778, registered 30.08.2013) and complies with the Declaration of Helsinki, the Guidelines on Good Clinical Practice (GCP-Directive) issued by the European Medicines Agency, as well as the Swiss law and Swiss regulatory authority requirements.
: Written informed consent for participation from the patient or in case of death or disability, from the next of kin or legal representative, was sought for every patient included into this trial.
: All authors have completed the ICMJE Form for Disclosure of Potential Conflicts of Interest. Baxter International Inc. (Deerfield, USA) supported this study through an unrestricted grant of SFR 150,000 and the provision of the oXiris filters evaluated in the same. No further disclosures are to be reported.